AQR Capital Management LLC reduced its position in shares of Enfusion, Inc. (NYSE:ENFN – Free Report) by 63.7% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 20,819 shares of the company’s stock after selling 36,554 shares during the period. AQR Capital Management LLC’s holdings in Enfusion were worth $177,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors also recently made changes to their positions in ENFN. Allspring Global Investments Holdings LLC bought a new stake in shares of Enfusion during the first quarter worth about $44,000. RiverPark Advisors LLC acquired a new stake in Enfusion during the 2nd quarter valued at approximately $68,000. Arizona State Retirement System acquired a new stake in Enfusion during the 2nd quarter valued at approximately $86,000. Price T Rowe Associates Inc. MD acquired a new stake in Enfusion during the 1st quarter valued at approximately $102,000. Finally, Quadrature Capital Ltd acquired a new stake in Enfusion during the 1st quarter valued at approximately $109,000. 81.05% of the stock is currently owned by institutional investors.
Enfusion Stock Performance
NYSE:ENFN opened at $8.77 on Friday. The company has a market capitalization of $1.12 billion, a PE ratio of 292.17, a P/E/G ratio of 2.49 and a beta of 0.92. Enfusion, Inc. has a fifty-two week low of $7.52 and a fifty-two week high of $10.45. The company has a 50 day simple moving average of $8.56 and a two-hundred day simple moving average of $8.88.
About Enfusion
Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.
See Also
- Five stocks we like better than Enfusion
- Health Care Stocks Explained: Why You Might Want to Invest
- Survey Reveals: America’s Most Coveted Businesses in 2024
- How to Use the MarketBeat Stock Screener
- Top 3 Stocks to Play Oil’s Potential Comeback Rally
- What Investors Need to Know About Upcoming IPOs
- Analysts See Growth in CrowdStrike Stock Despite July Setback
Want to see what other hedge funds are holding ENFN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enfusion, Inc. (NYSE:ENFN – Free Report).
Receive News & Ratings for Enfusion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enfusion and related companies with MarketBeat.com's FREE daily email newsletter.